$3.94
1.42% yesterday
Nasdaq, Nov 25, 09:47 pm CET
ISIN
US68554V1089
Symbol
OSUR

OraSure Technologies, Inc. Stock price

$3.93
-0.10 2.48% 1M
-0.92 18.97% 6M
-4.27 52.07% YTD
-3.36 46.09% 1Y
-5.30 57.42% 3Y
-3.95 50.13% 5Y
-5.27 57.28% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
+0.05 1.29%
ISIN
US68554V1089
Symbol
OSUR
Sector

Key metrics

Market capitalization $293.16m
Enterprise Value $25.70m
P/E (TTM) P/E ratio 26.13
EV/FCF (TTM) EV/FCF 0.40
EV/Sales (TTM) EV/Sales 0.11
P/S ratio (TTM) P/S ratio 1.31
P/B ratio (TTM) P/B ratio 0.69
Revenue growth (TTM) Revenue growth -50.46%
Revenue (TTM) Revenue $224.26m
EBIT (operating result TTM) EBIT $-1.29m
Free Cash Flow (TTM) Free Cash Flow $64.01m
Cash position $278.57m
EPS (TTM) EPS $0.15
P/E forward negative
P/S forward 1.58
EV/Sales forward 0.14
Short interest 1.80%
Show more

Is OraSure Technologies, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

OraSure Technologies, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a OraSure Technologies, Inc. forecast:

1x Buy
20%
4x Hold
80%

Analyst Opinions

5 Analysts have issued a OraSure Technologies, Inc. forecast:

Buy
20%
Hold
80%

Financial data from OraSure Technologies, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
224 224
50% 50%
100%
- Direct Costs 122 122
54% 54%
54%
103 103
45% 45%
46%
- Selling and Administrative Expenses 66 66
18% 18%
29%
- Research and Development Expense 26 26
26% 26%
12%
11 11
85% 85%
5%
- Depreciation and Amortization 12 12
44% 44%
5%
EBIT (Operating Income) EBIT -1.29 -1.29
103% 103%
-1%
Net Profit 11 11
77% 77%
5%

In millions USD.

Don't miss a Thing! We will send you all news about OraSure Technologies, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

OraSure Technologies, Inc. Stock News

Neutral
GlobeNewsWire
8 days ago
BETHLEHEM, Pa., Nov. 18, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) announced today that the company is scheduled to participate in the following investor conference:
Neutral
Seeking Alpha
19 days ago
OraSure Technologies, Inc. (OSUR) Q3 2024 Earnings Call Transcript
Neutral
GlobeNewsWire
20 days ago
Q3 GAAP EPS of $(0.06) ; Q3 Non-GAAP EPS of $(0.01) OraQuick® HCV Self-test receives initial orders following receipt of WHO pre-qualification status Expanding Sample Management applications into blood proteomics Exiting Risk Assessment testing business to focus on markets with attractive growth opportunities BETHLEHEM, Pa., Nov. 06, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: ...
More OraSure Technologies, Inc. News

Company Profile

OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. The OSUR segment offer oral fluid diagnostic products and specimen collection devices. The DNAG segment produces specimen collection kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. The company was founded by Michael J. Gausling in May 2000 in and is headquartered in Bethlehem, PA.

Head office United States
CEO Carrie Manner
Employees 638
Founded 2000
Website www.orasure.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today